Abstract:Background Currently, over 90 genetic loci have been found to be associated with Parkinson’s disease (PD) in genome-wide association studies, nevertheless, the effects of these genetic variants on the clinical features and brain structure of PD patients are largely unknown. Objective This study investigated the effects of microtubule-associated protein tau ( MAPT ), rs17649553 (C>T), a genetic variant associated with reduced PD risk, on the functional and structural networks of PD patients. Methods Totally 83 PD subjects from Parkinson’s Progression Markers Initiative database were included for this study. They all received structural and functional magnetic resonance imaging and whole exome sequencing. The effects of MAPT rs17649553 on brain structural and functional networks were systematically assessed. Results MAPT rs17649553 T allele was associated with better verbal memory in PD patients. In addition, MAPT rs17649553 significantly reshaped the topology of gray matter covariance network and white matter network but not that of functional network. Both the network metrics in gray matter covariance network and white matter network were correlated with verbal memory, however, the mediation analysis showed that it was the small-worldness topology in white matter network that mediated the effects of MAPT rs17649553 on verbal memory. Conclusion In sum, we proposed that MAPT rs17649553 T allele was associated with superior structural network topology and better verbal memory in PD. Future studies are needed to determine the role of MAPT rs17649553 in PD initiation and progression. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This work was supported by grants from the National Key Research and Development Program (2016YFC1306505) and the National Natural Science Foundation of China (81471287, 81071024, 81171202). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: [www.ppmiinfo.org][1] I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes All data produced in the present study are available upon reasonable request to the authors <http://www.ppmi-info.org/data> [1]: https://www.ppmiinfo.org

Association Between MAPT Haplotype and Memory Function in Patients with Parkinson's Disease and Healthy Aging Individuals.

Genetic Variants of PICALM Rs541458 Modulate Brain Spontaneous Activity in Older Adults with Amnestic Mild Cognitive Impairment

Effects of<i>MAPT</i>rs17649553 on Structural Network Integrity and Verbal Memory in Parkinson’s Disease

MAPT rs17649553 T allele is associated with better verbal memory and higher small-world properties in Parkinson's disease

Further validation of the association between MAPT haplotype-tagging polymorphisms and Alzheimer's disease: neuropsychological tests, cerebrospinal fluid biomarkers, and APOE genotype

Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.

Association study of candidate gene polymorphisms of tau protein pathway with amnestic mild cognitive impairment

Genome-wide Association Study Identifies MAPT Locus Influencing Human Plasma Tau Levels.

Variants in the SNCA Gene Associate with Motor Progression While Variants in the MAPT Gene Associate with the Severity of Parkinson's Disease.

MAPT Rs242557 Variant is Associated with Hippocampus Tau Uptake on 18F-AV-1451 PET in Non-Demented Elders.

Selective brain gray matter atrophy associated with APOE ε4 and MAPT H1 in subjects with mild cognitive impairment.

Full Sequencing and Haplotype Analysis of MAPT in Parkinson's Disease and Rapid Eye Movement Sleep Behavior Disorder

Impact of cognition-related single nucleotide polymorphisms on brain imaging phenotype in Parkinson's disease.

Effects of MAPT rs17649553 on Structural Network Integrity and Verbal Memory in Parkinson’s Disease

Polygenic hazard score modified the relationship between hippocampal subfield atrophy and episodic memory in older adults

MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy

The Distinct Cognitive Syndromes of Parkinson's Disease: 5 Year Follow-Up of the CamPaIGN Cohort

Association analysis of MAPK1 gene and Alzheimer's disease in Han Chinese

Association between Alzheimer's disease, MAPT gene mutation and some biochemical biomarkers

MAPT As a Predisposing Gene for Sporadic Amyotrophic Lateral Sclerosis in the Chinese Han Population.

Genetic Risks of Alzheimer's by APOE and MAPT on Cortical Morphology in Young Healthy Adults.